![](/img/cover-not-exists.png)
Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2-Normal, Node-Positive Breast Cancer: BCIRG-005 Trial
Eiermann, W., Pienkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M., Sauter, G., Lindsay, M.-A., Riva, A., Buyse, M., Drevot, PVolume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.28.5437
Date:
October, 2011
File:
PDF, 320 KB
english, 2011